Renal AT2 Receptors in Hypertension
Renal AT2 Receptors in Hypertension
批准号:
8242704
负责人:
ROBERT MUNSON CAREY
金额:
$42.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-15 至 2014-03-31
关键词:
AGTR2 geneAdultAffectAgeAgonistAngiotensin IIAngiotensin IIIAnimalsApicalBlood PressureBlood VesselsBlood capillariesCell ProliferationCell membraneCellsCessation of lifeDataDefectDevelopmentDiseaseDopamineDopamine D1 ReceptorElectrolyte BalanceElectrolytesEnd stage renal failureEnzymesEssential HypertensionExcretory functionExhibitsFenoldopamFluid BalanceFunctional disorderGoalsHeartHeart failureHormonalHumanHypertensionInbred SHR RatsInbred StrainInfusion proceduresKidneyLaboratoriesLeadLigandsLiquid substanceMediatingMediator of activation proteinModelingMolecularMolecular TargetMyocardial InfarctionNatriuresisNephronsPeptidesPerfusionPlayPopulationPrincipal InvestigatorProximal Kidney TubulesRattusReceptor ActivationReceptor InhibitionRecruitment ActivityRegulationRenal functionRenin-Angiotensin SystemRiskRisk FactorsRodentRoleSiteSodiumSodium ChlorideSprague-Dawley RatsStimulusStrokeTechniquesTestingTimeTransplantationVasodilationWaterWestern Worldalanine aminopeptidaseapical membraneblood pressure regulationcapillarycell growthdisabilityhypertension preventionin vivoprematurepressurepublic health relevancereceptorreceptor expressionresponsesalureticurinaryvasoconstriction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The renin-angiotensin system (RAS) is a hormonal cascade of major critical importance to the regulation of blood pressure, fluid and electrolyte balance and kidney function. Angiotensin II (Ang II), the main effector peptide of the RAS, acts at two major receptors, AT1 and AT2. The vast majority of Ang II actions are mediated by the AT1 receptor, including cell proliferation, vasoconstriction and antinatriuresis. Much less is known concerning the functions of the AT2 receptor. Recent studies indicate that the AT2 receptor inhibits cell growth and induces vasodilation opposing the effects of Ang II at AT1 receptors. The role of the AT2 receptors in fluid and electrolyte homeostatsis is unknown. The Principal Investigator has preliminary data demonstrating that the AT2 receptor mediates natriuresis in normal Sprague-Dawley rats and that the heptapeptide derivative of Ang II, des-aspartyl-Ang II (Ang III), is the preferred agonist. The Principal Investigator also has preliminary data strongly suggesting that dopamine D1-receptor stimulation induces increased renal proximal tubule cell apical membrane AT2 receptor expression and that inhibition of AT2 receptors abolishes D1 receptor-induced natriuresis. This project will explore in depth the site and mechanisms of AT2 receptor-induced natriuresis. The project will focus on two specific hypotheses: (1) AT2 receptors in the renal proximal tubule are key mediators of the natriuretic responses to Ang III, AT1 receptor blockade, D1 receptor activation and increased renal perfusion pressure; and (2) AT2 receptor-mediated natriuresis is defective in young pre-hypertensive spontaneously hypertensive rats (SHR). The project will apply a combination of state-of-the-art in vivo and cell and molecular techniques to clarify the role of the AT2 receptor in sodium excretion in hypertension. These studies will help clarify the pathophysiology of human primary hypertension, a disorder affecting one-quarter after adult population in the Western world.
PUBLIC HEALTH RELEVANCE: Hypertension (high blood pressure), present in over 25% of the population of the Western world, is a major risk factor for heart and blood vessel disease leading to premature death and disability. Retention of salt and water by the kidney is required for hypertension to develop. This application will increase our understanding of the mechanisms whereby the kidney renin-angiotensin system regulates salt and water excretion, suggesting new molecular targets for the treatment and prevention of hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Renal AT2 Receptors in Hypertension
-
批准号:10320944
-
项目类别:
-
资助金额:$68.2万
-
财政年份:2021
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
Renal AT2 Receptors in Hypertension
-
批准号:9460298
-
项目类别:
-
资助金额:$56.66万
-
财政年份:2016
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
Renal AT2 Receptors in Hypertension
-
批准号:9249632
-
项目类别:
-
资助金额:$56.66万
-
财政年份:2016
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE
-
批准号:8167153
-
项目类别:
-
资助金额:$1.6万
-
财政年份:2010
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
Renal AT2 Receptors in Hypertension
-
批准号:7887245
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2010
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
URINARY ANGIOTENSINOGEN EXCRETION IN NORMALS AND PATIENTS WITH TYPE II DM
-
批准号:8167172
-
项目类别:
-
资助金额:$10.56万
-
财政年份:2010
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
Renal AT2 Receptors in Hypertension
-
批准号:8441622
-
项目类别:
-
资助金额:$40.24万
-
财政年份:2010
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
Renal AT2 Receptors in Hypertension
-
批准号:8058747
-
项目类别:
-
资助金额:$43.18万
-
财政年份:2010
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
Natriuretic mechanisms of AT2 receptors
-
批准号:7894698
-
项目类别:
-
资助金额:$45.21万
-
财政年份:2009
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
CLINICAL TRIAL: EFFECT OF GENE VARIANTS ON DOPAMINE RECEPTOR NATRIURETIC RESPONS
-
批准号:7951502
-
项目类别:
-
资助金额:$8.97万
-
财政年份:2009
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE
-
批准号:7951466
-
项目类别:
-
资助金额:$25.64万
-
财政年份:2009
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
Natriuretic mechanisms of AT2 receptors
-
批准号:7523729
-
项目类别:
-
资助金额:$44.48万
-
财政年份:2009
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
URINARY ANGIOTENSINOGEN EXCRETION IN NORMALS AND PATIENTS WITH TYPE II DM
-
批准号:7951495
-
项目类别:
-
资助金额:$4.58万
-
财政年份:2009
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
CLINICAL TRIAL: EFFECT OF GENE VARIANTS ON DOPAMINE RECEPTOR NATRIURETIC RESPONS
-
批准号:7718595
-
项目类别:
-
资助金额:$25.08万
-
财政年份:2008
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE
-
批准号:7718548
-
项目类别:
-
资助金额:$48.78万
-
财政年份:2008
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE
-
批准号:7606694
-
项目类别:
-
资助金额:$94.97万
-
财政年份:2007
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
PRESSURE NATRIURESIS MEDIATED BY EXTRACELLULAR cGMP
-
批准号:7103661
-
项目类别:
-
资助金额:$42.75万
-
财政年份:2005
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
PRESSURE NATRIURESIS MEDIATED BY EXTRACELLULAR cGMP
-
批准号:7471463
-
项目类别:
-
资助金额:$42.52万
-
财政年份:2005
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE
-
批准号:7205516
-
项目类别:
-
资助金额:$4.81万
-
财政年份:2005
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
PRESSURE NATRIURESIS MEDIATED BY EXTRACELLULAR cGMP
-
批准号:7261427
-
项目类别:
-
资助金额:$42.13万
-
财政年份:2005
-
负责人:ROBERT MUNSON CAREY
-
依托单位:
海外基金